ArticleBlood advances2025

Targeting RNA modification and mitochondrial metabolism cross talk in leukemic stem cells with CDK7 inhibitor TGN-1062.

Hyunjun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.